Porcine Reproductive and Respiratory Syndrome Virus

Overview and Taxonomy of Porcine Reproductive and Respiratory Syndrome Virus

Porcine reproductive and respiratory syndrome virus (PRRSV) represents one of the most economically devastating pathogens confronting the global swine industry, a status that has persisted for over three decades since its initial recognition in the late 1980s [1, 4, 17]. The virus is the etiological agent of porcine reproductive and respiratory syndrome (PRRS), a disease characterized by late-term reproductive failure in breeding animals and severe respiratory distress in piglets and growing pigs, often compounded by a marked susceptibility to secondary bacterial infections [4, 14, 20]. The World Organisation for Animal Health (WOAH) lists PRRS as a notifiable disease due to its profound impact on international trade and animal health, underscoring its significance as a transboundary animal pathogen. The annual economic losses attributed to PRRSV are staggering, with estimates in the United States alone exceeding USD 664 million annually, a figure that has risen substantially from earlier projections as the true cost of reproductive losses in the breeding herd has become more fully appreciated [18, 32]. In Europe, farm-level losses in a moderately affected farrow-to-finish operation can reach a median of over €650,000, highlighting the pervasive and persistent financial burden imposed by this virus [18].

Taxonomic Classification and Viral Morphology

PRRSV is an enveloped, positive-sense, single-stranded RNA virus belonging to the family Arteriviridae, within the order Nidovirales [4, 33]. The Arteriviridae family, which also includes equine arteritis virus, lactate dehydrogenase-elevating virus of mice, and simian hemorrhagic fever virus, is defined by its common replicative strategy and virion architecture. Historically, the species was divided into two distinct genotypes based on antigenic and genomic differences: PRRSV-1 (European genotype, prototype strain Lelystad virus) and PRRSV-2 (North American genotype, prototype strain VR-2332) [4, 33, 35]. Recent taxonomic revisions by the International Committee on Taxonomy of Viruses (ICTV) have reclassified these as Betaarterivirus suid 1 (PRRSV-1) and Betaarterivirus suid 2 (PRRSV-2), though the field continues to use the traditional nomenclature for practical clarity [7, 9]. The viral genome, approximately 15 kilobases in length, contains at least ten open reading frames (ORFs). ORF1a and ORF1b occupy the 5' proximal three-quarters of the genome and encode two large polyproteins, pp1a and pp1ab, which are proteolytically processed into at least 16 nonstructural proteins (nsps) essential for viral replication and transcription [15, 34, 38]. The 3' end of the genome encodes the structural proteins: GP2a, E (envelope), GP3, GP4, GP5, M (matrix), and N (nucleocapsid) [3, 5, 12]. Among these, GP5 is the major glycoprotein and a primary target for neutralizing antibodies, while the highly conserved N protein is abundantly expressed and serves as a key antigen for diagnostic detection [3, 5].

Genetic Diversity and Lineage Structure

The hallmark of PRRSV biology is its extraordinary genetic and antigenic diversity, a feature that fundamentally complicates disease control and vaccine development [1, 4, 21]. This diversity arises from two principal mechanisms: the high mutation rate inherent to its error-prone RNA-dependent RNA polymerase (RdRp), encoded by nsp9, and the frequent occurrence of recombination events between co-infecting strains [15, 19, 21]. The virus exists as a quasispecies swarm within individual hosts and across populations, where a multitude of closely related but genetically distinct variants co-circulate, enabling rapid adaptation to host immune pressures and environmental changes [21, 40].

Phylogenetic analyses, most commonly based on ORF5 (encoding GP5), have delineated the global population of PRRSV-2 into a series of distinct lineages. In China, where the epidemiological landscape is particularly complex, at least four major lineages of PRRSV-2 are recognized: Lineage 1 (including NADC30-like and NADC34-like strains), Lineage 3 (QYYZ-like strains), Lineage 5 (BJ-4-like, closely related to the VR-2332 vaccine strain), and Lineage 8 (CH-1a-like and the highly pathogenic HP-PRRSV strains) [1, 9, 16, 19]. The emergence and sequential dominance of these lineages over time has been a striking feature of PRRSV epidemiology. For instance, in the United States, lineage 1 (particularly sub-lineage 1A, often identified by RFLP typing as 1-7-4) has become the predominant circulating group since 2014, displacing previously dominant lineage 9 strains [22, 23]. This dynamic turnover is consistent with an immune-mediated selection model, where population immunity against the dominant variant drives the emergence and expansion of antigenically distinct sub-lineages [22]. More recently, the NADC30-like strains (Lineage 1) and NADC34-like strains (sub-lineage 1.5) have become endemic in China, with the latter demonstrating the potential to become a dominant epidemic strain due to its increasing prevalence and genetic diversification [10, 25, 35].

The Expanding Repertoire of Recombinant Strains

Recombination represents a potent evolutionary force in PRRSV, capable of generating chimeric viruses with dramatically altered pathogenicity and antigenic profiles [16, 19, 21]. The frequency of interlineage and intralineage recombination events has increased substantially in recent years, driven in part by the co-circulation of diverse field strains and the widespread use of modified live virus (MLV) vaccines [1, 17, 24, 26]. High-frequency recombination hot spots have been identified in the genome, particularly within nsp9 and the region spanning ORF2 to ORF4 (encoding GP2 to GP4), suggesting that these areas are prone to template switching during RNA replication [13, 16, 19]. In China, a myriad of complex recombinants have been documented, involving parental strains from Lineages 1, 3, 5, and 8. A notable example is the emergence of highly pathogenic recombinants that combine the genetic backbone of NADC30-like strains with virulence determinants from HP-PRRSV (Lineage 8) or antigenic regions from QYYZ-like strains (Lineage 3) [8, 11, 36]. One such strain, SCcd2020, a multiple recombinant virus incorporating sequences from NADC30-like, NADC34-like, and JXA1-like (HP-PRRSV) strains, caused 60% mortality in experimentally infected piglets, illustrating the potential for recombination to generate viruses of exceptional virulence [8]. Similarly, in Europe, a recombinant virus derived from two different PRRSV-1 MLV vaccine strains (Amervac and 96V198) caused severe outbreaks in Danish swine herds, demonstrating that vaccine-derived recombinants can be both highly transmissible and pathogenic [24]. The detection of recombinants involving MLV strains and field viruses in the United States further underscores the biosecurity risks associated with live vaccine use [26].

Nsp2 Polymorphism and the Highly Pathogenic PRRSV Phenotype

The nsp2 coding region is a recognized hotspot for genetic variation, characterized by frequent insertions, deletions, and substitutions that serve as molecular markers for distinct viral lineages and have been linked to virulence modulation [6, 9, 16]. The emergence of HP-PRRSV in China in 2006 was marked by a characteristic discontinuous 30-amino-acid deletion in the nsp2 region of Lineage 8 strains, a pattern that became a hallmark of this highly virulent lineage [1, 6, 9]. More recently, NADC30-like strains have been defined by a distinctive 131-amino-acid deletion in nsp2, relative to the VR-2332 reference, a pattern that is now widely used for molecular classification [8, 10, 35]. Intriguingly, the nsp2 region itself appears to function as a critical virulence determinant. Chimeric virus studies have demonstrated that swapping the nsp2 from an HP-PRRSV strain into a low-virulence NADC30-like backbone confers enhanced pathogenic properties, including prolonged high fever, severe lung hemorrhage, and a robust induction of proinflammatory cytokines [6]. This suggests that nsp2 genetic variation directly modulates the host's immune response, influencing both acute virulence and the virus's ability to establish persistent infection [6, 12]. Furthermore, the nsp2 indel patterns provide a refined tool for classifying PRRSV-2 strains, with at least 25 distinct patterns identified through systematic analysis of global isolates [16].

Cellular Tropism and the Molecular Basis of Host Restriction

The host range of PRRSV is exquisitely restricted to cells of the porcine monocyte/macrophage lineage, with porcine alveolar macrophages (PAMs) and pulmonary intravascular macrophages serving as the primary targets of natural infection [4, 39, 42]. This restricted tropism is governed by the interaction between viral surface glycoproteins (GP2a, GP3, and GP4) and specific host cell receptors, chief among them being the scavenger receptor CD163 [27, 31, 37, 39]. CD163, a transmembrane protein expressed on the surface of mature macrophages, is an essential entry mediator for both PRRSV-1 and PRRSV-2 [30, 31]. The interaction occurs specifically via scavenger receptor cysteine-rich domain 5 (SRCR5) of CD163 with the GP2a/GP3/GP4 heterotrimer on the viral envelope [27, 37]. The critical dependence on this receptor has been elegantly demonstrated through gene-editing studies: pigs lacking the SRCR5 domain of CD163 produced by CRISPR-Cas9 technology are completely resistant to infection by both PRRSV species, exhibiting no viremia, clinical signs, or seroconversion following challenge [27, 30, 31]. This genetic resistance, which does not seem to impair normal physiological function of the edited receptors, represents a revolutionary approach to PRRS control and is now being scaled into commercial breeding populations, marking a paradigm shift from management-based to genetic-based disease mitigation [2, 31].

In addition to CD163, the virus requires heparan sulfate and other co-receptors for initial attachment, but CD163 abundance on the macrophage surface acts as a pivotal "switch" for productive infection. Cells with low CD163 expression (approximately 20% of control levels) do not support PRRSV infection, while those with moderate expression support only limited infection, and efficient, robust replication only occurs in cells with high CD163 abundance [39]. Age-related susceptibility to PRRSV, whereby nursery pigs are far more susceptible to severe disease than adults, does not appear to correlate with differences in CD163 expression levels, suggesting that post-entry, intracellular innate immune mechanisms, such as the efficiency of type I interferon induction, are the primary determinants of age-dependent resistance [42].

Implications of Taxonomic Diversity for Disease Control

The staggering genetic and antigenic diversity of PRRSV presents a formidable barrier to effective vaccination and herd-level control. Commercial modified live virus vaccines, while capable of inducing robust protection against homologous challenge, provide only partial and inconsistent cross-protection against heterologous field strains [17, 40, 41]. The sheer number of co-circulating lineages, sub-lineages, and antigenic variants means that a vaccine developed against one strain may be largely ineffective against another, a phenomenon that has been repeatedly documented in field and experimental settings [17, 40]. Furthermore, the safety of MLVs is a persistent concern, given evidence that these live vaccines can revert to virulence, recombine with field strains to generate novel pathogenic variants, and even contribute to the genetic diversity of the circulating viral pool, a phenomenon that has been termed a "leaky" vaccine [17, 24, 26]. This has led to a growing realization that effective PRRS control will require a multifaceted approach, integrating advanced biosecurity, regional disease management programs, strategic vaccination tailored to local circulating strains, and the eventual deployment of genetically resistant pigs [2, 10, 28, 29, 41]. The complex taxonomy of PRRSV is not merely an academic curiosity; it is the central, inescapable biological reality that must be confronted in any serious attempt to mitigate the impact of this devastating swine pathogen.

Molecular Pathogenesis and Virulence Determinants of PRRSV

Porcine reproductive and respiratory syndrome virus (PRRSV), a member of the family Arteriviridae within the order Nidovirales, remains one of the most economically devastating pathogens affecting the global swine industry, with annual losses in the United States alone estimated at approximately US $664 million and far greater costs worldwide [32]. This single-stranded, positive-sense RNA virus is characterized by an exceptionally high mutation rate, extensive genetic diversity, and a sophisticated arsenal of mechanisms that subvert host defenses and drive pathogenesis [1, 21]. The molecular pathogenesis of PRRSV is a multifactorial process, governed by a complex interplay between viral structural and nonstructural proteins and the host cellular machinery, particularly within the porcine alveolar macrophage (PAM), the primary target cell. A deep understanding of the virulence determinants and the molecular strategies employed by PRRSV to establish infection, evade immunity, and cause disease is essential for designing rational control measures, including next-generation vaccines and antiviral therapies.

Viral Entry and Cellular Tropism: The Role of CD163

The narrow tropism of PRRSV for cells of the monocyte/macrophage lineage is fundamentally dictated by the expression of the scavenger receptor CD163 on the surface of these cells [37]. Extensive research has unequivocally identified CD163 as an essential entry mediator for both PRRSV-1 and PRRSV-2, confirming earlier studies [2, 27]. Specifically, the scavenger receptor cysteine-rich domain 5 (SRCR5) of CD163 has been pinpointed as the critical interaction site for the virus. This was elegantly demonstrated through gene-editing experiments where pigs lacking the SRCR5 domain (ΔSRCR5 CD163) were completely resistant to infection by highly virulent PRRSV-1 and PRRSV-2 strains, showing no viremia, clinical signs, or antibody response [27, 31]. The virus-receptor interaction, however, is not a simple on-off switch. The abundance of CD163 on the cell surface acts as a pivotal determinant of infection efficiency. Studies have shown that PAMs with low CD163 abundance are resistant to PRRSV infection, while only cells with high CD163 levels support efficient viral replication, highlighting that permissiveness is a quantitative trait [39]. This is further supported by the generation of genetically edited pigs carrying a modified CD163 allele, which have shown complete resistance to PRRSV-2 infection by preventing uncoating and genome release post-entry, thereby providing a promising avenue for breeding PRRSV-resistant commercial swine populations [2, 30].

Nonstructural Proteins: The Replicase Complex as a Virulence Hub

The replicase polyproteins, encoded by ORF1a and ORF1b, are processed into at least 16 nonstructural proteins (nsps) that assemble into the viral replication and transcription complex (RTC) [33]. These nsps are not merely enzymatic engines for genome replication; they are pivotal virulence factors that orchestrate immune evasion and host cellular manipulation. nsp1 (comprising nsp1α and nsp1β), for example, acts as a potent immunomodulator, suppressing early inflammatory responses by decreasing transcripts of host genes involved in cell signaling and protection, such as Fosb and Gdf15 [57]. nsp2 is a prominent virulence determinant and a rapidly evolving protein, with its genetic variations (deletions, insertions, and recombination) directly modulating viral pathogenicity and persistence [6]. Comparative studies using chimeric viruses between a highly pathogenic PRRSV (HP-PRRSV) and a low-virulence NADC30-like strain revealed that the nsp2 from HP-PRRSV was critical for inducing prolonged high fever, severe lung hemorrhage, and a significant surge in proinflammatory cytokines like IL-1β and TNF-α [6].

The core enzymes of the RTC, nsp9 (RNA-dependent RNA polymerase, RdRp) and nsp10 (helicase), are central to replication fidelity and are targeted by host antiviral factors. A comprehensive interaction map of PRRSV nsps revealed a complex network centered on ORF1b-encoded proteins (nsp9 and nsp10), which are recruited to membrane-anchored nsps (nsp2, nsp3, nsp5) for proper RTC assembly [38]. The host zinc finger antiviral protein (ZAP) directly interacts with nsp9 to inhibit replication, a host defense that PRRSV must overcome [48]. nsp11, which possesses a nidovirus-specific endoribonuclease (NendoU) activity, is a master antagonist of type I interferon (IFN) signaling. It acts through a dual mechanism: by inhibiting IFN production and by directly targeting IRF9, a key transcription factor in the IFN-signaling pathway. The nsp11-IRF9 interaction, independent of its NendoU activity, impairs the formation of the ISGF3 complex, thereby blocking the transcription of interferon-stimulated genes (ISGs) [49]. The virus also manipulates the unfolded protein response (UPR); the viral protein GP2a targets the UPR master regulator GRP78 for degradation, while products of nsp2 and nsp3 sequester the transcription factor ATF4 to viral replication complexes, repurposing the host stress response to promote viral RNA synthesis [34].

Structural Proteins: Immune Evasion and Apoptosis

The five principal structural proteins, GP5, M, N, GP2, and GP4, are crucial not only for virion assembly but also for direct interactions with the host. GP5, encoded by ORF5, is a primary target for neutralizing antibodies. However, it is also a key driver of antigenic diversity and immune evasion. The GP5 protein contains a conserved epitope flanked by hypervariable regions and N-glycosylation sites, which act as a glycan shield to mask critical neutralizing epitopes, a common phenomenon among viruses [5, 37]. The rapid mutation of GP5, especially within the ectodomain, allows for continuous escape from neutralizing antibodies, making vaccine development a persistent challenge [5, 44]. The N (nucleocapsid) protein is an immunodominant but poorly neutralizing antigen, and while it is highly expressed and used for diagnostics, it may also contribute to modulating host immunity [3]. The envelope (E) protein employs a more insidious tactic, directly degrading host antiviral factors. It interacts with and promotes the autophagic degradation of DDX10, a helicase that positively regulates type I IFN production, thereby neutralizing a critical host defense [45]. Similarly, the E protein targets the antiviral enzyme cholesterol 25-hydroxylase (CH25H) for degradation via the ubiquitin-proteasome pathway, counteracting the production of 25-hydroxycholesterol, a potent antiviral molecule [53].

Autophagy, Lipophagy, and Apoptosis Modulation

PRRSV has evolved to co-opt the host’s autophagic machinery for its own replicative benefit. The virus induces a non-canonical autophagic response that provides membranous scaffolds for replication and aids in lipid metabolism. PRRSV infection is known to activate lipophagy by downregulating NDRG1, a protein that normally suppresses autophagy. This NDRG1 deficiency leads to increased lipophagy, releasing free fatty acids that provide energy and building blocks for viral replication [52]. Furthermore, the E protein simultaneously triggers selective autophagy to degrade antiviral DDX10, showcasing a direct link between viral protein function, autophagy subversion, and innate immune evasion [45]. Apoptosis is another battlefield; while PRRSV must avoid early cell death to complete its replication cycle, it ultimately induces apoptosis to facilitate viral spread and contribute to pathogenesis, particularly in lung tissue, leading to the characteristic interstitial pneumonia [54, 56]. The induction of apoptosis is multifactorial, with GP5 playing a role, alongside other viral proteins, in triggering cell death pathways through the upregulation of TNF-α and IL-1β [51, 55].

Immune Subversion and the "Cytokine Storm"

The hallmark of PRRSV pathogenesis is its profound suppression of innate immunity, particularly type I IFN production, coupled with a paradoxical and damaging over-exuberant inflammatory response in the late stages. This subversion is orchestrated by multiple viral proteins, including nsp1, nsp2, and nsp11, which block the RIG-I/MDA5 and JAK-STAT signaling pathways at several points [46, 47]. The interferon-suppressive effects allow the virus to replicate unimpeded in the early stages, leading to prolonged viremia and persistent infection [1]. Simultaneously, the virus triggers a dysregulated inflammatory cascade. In highly pathogenic PRRSV (HP-PRRSV) infections, this manifests as a "cytokine storm," characterized by elevated levels of IL-1β, TNF-α, and other chemokines [6, 51]. These molecules, secreted by infected PAMs, have direct pathogenic consequences. As uncovered in recent studies, IL-1β and TNF-α lead to disruption of the pulmonary microvascular endothelial barrier by synergistically downregulating claudin-8 and upregulating claudin-4, directly causing the vascular leakage, edema, and acute lung injury (ALI) seen in severe PRRS [43]. This intricate interplay between immunosuppression and immunopathology is a central theme in PRRSV virulence, transforming a moderately pathogenic virus into a devastating one [4]. The dysregulation of Notch signaling further contributes to this inflammatory imbalance, promoting the secretion of TNF-α and IL-1β without affecting viral replication itself [51].

Recombination as a Driver of Virulence Evolution

The quasispecies nature of PRRSV, coupled with its error-prone replication, provides a fertile ground for the emergence of new variants. However, recombination is a particularly potent evolutionary force that accelerates the acquisition of virulence determinants [1, 21]. Recombination events are frequent, occurring not only between wild-type field strains but also between field and vaccine strains, with modified live vaccine (MLV) viruses acting as common parents [24, 26]. Extensive analysis of PRRSV genomes has identified recombination "hot spots" in the nsp2, nsp9, and GP2-GP3 regions, indicating that these areas are particularly prone to exchange [13, 16]. The result is the generation of novel, highly pathogenic chimeras, such as the recombinant between NADC34-like and QYYZ-like strains that caused significant mortality in piglets, or the triple-recombinants from lineages 1, 5, and 8 that emerged in China [8, 11, 36]. The widespread use of MLVs, while protecting against homologous challenge, paradoxically contributes to this pathogenic evolution by providing a pool of attenuated virus that can recombine with circulating field strains, potentially restoring virulence and generating novel immune escape variants [17, 21]. This continuous emergence of novel, recombinant field strains, such as the highly virulent NADC30-like and RFLP 1-7-4 variants, is a critical challenge for global disease control and vaccine development [10, 23, 35, 50].

Epidemiology and Global Genetic Diversity of PRRSV

The emergence of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) in the late 1980s precipitated one of the most economically consequential pandemics in modern livestock agriculture, fundamentally reshaping the global swine industry. The virus was first recognized simultaneously in the United States in 1987 and in Europe in 1991, and within a span of three decades, it established endemicity in virtually every major pork-producing nation, with the notable exceptions of Australia, New Zealand, and parts of Scandinavia where eradication has been maintained through rigorous biosecurity and stamping-out policies [1, 4, 33]. The economic toll is staggering: annual losses in the United States alone were estimated at approximately $664 million in a comprehensive 2011 analysis, with a 45% allocation to breeding herd losses, while a European modeling study for a single 1000-sow farrow-to-finish farm calculated annual losses ranging from €75,724 (slight severity) to €650,090 (severe infection across all production stages) [18, 32]. The World Organisation for Animal Health (WOAH) classifies PRRS as a notifiable disease in many jurisdictions, underscoring its transboundary significance and the imperative for coordinated global surveillance [29, 59].

Global Distribution and Species Classification

PRRSV exists as two distinct viral species, now formally recognized by the International Committee on Taxonomy of Viruses as Betaarterivirus suid 1 (PRRSV-1, formerly European genotype) and Betaarterivirus suid 2 (PRRSV-2, formerly North American genotype), a taxonomic revision that reflects the deep phylogenetic divergence between these clades, which share only approximately 60% nucleotide identity across the genome [7, 9, 31]. Historically, PRRSV-1 predominated across Europe while PRRSV-2 dominated the Americas and Asia; however, this geographic segregation has eroded dramatically over the past two decades due to globalized trade in live pigs and semen, resulting in a complex, overlapping distribution where both species now circulate sympatrically within many regions, including China, South Korea, Taiwan, and increasingly continental Europe [1, 7, 61]. The introduction of PRRSV-2 into China is traced to the importation of breeding stock from North America in the mid-1990s, with the first isolation of the Chinese prototype CH-1a strain in 1996 sharing high homology with the US VR-2332 strain [9, 19]. In Europe, PRRSV-2 strains have been sporadically detected since the early 2000s, often linked to the use of modified live vaccines (MLVs) derived from North American isolates [17, 59]. Conversely, PRRSV-1 has gained footholds in Asia, with its first detection in mainland China reported in 2006 and subsequent spread to over 23 provinces, representing a worrying trend given that PRRSV-1 vaccines are not authorized for use in China [7, 13, 58]. A particularly illustrative example of transcontinental spillover was the 2018 outbreak of PRRSV-1 in Taiwan, where sequencing revealed near-identity (98.2%) to a European vaccine strain, NPUST2789, implicating vaccine-derived virus as the source of reproductive failure in a naïve population [61].

Phylogeographic Dynamics and Lineage Architecture

The genetic architecture of PRRSV is characterized by a hierarchical lineage structure that reflects both historical introduction events and ongoing local diversification. For PRRSV-2, an internationally adopted classification system based on phylogenetic analysis of the ORF5 gene recognizes nine major lineages (Lineages 1 through 9), with Lineage 1 further subdivided into multiple sublineages including 1A (RFLP 1-7-4), 1B (NADC30-like), and 1C (NADC34-like) [16, 22, 23]. In the United States, decades of longitudinal surveillance have revealed remarkable temporal dynamics: Lineage 9 was the predominant circulating clade from 2009 to 2010 but collapsed to near extinction (0.5% of sequences) by 2014, coinciding with the explosive emergence of Lineage 1 as the dominant lineage, a pattern consistent with immune-mediated selection where population immunity drives sequential turnover of viral variants [22]. The RFLP 1-7-4 sublineage (L1A) emerged in the US in 2013-2014 and rapidly became a major cause of severe respiratory outbreaks, subsequently spreading to Peru and China, demonstrating the capacity for long-distance dissemination via international trade [50, 63, 65]. Phylodynamic analysis of over 4,000 ORF5 sequences from a single US swine-dense region documented that the population genetic diversity of NADC30-like viruses is undergoing a detectable decrease, suggesting the potential emergence of a dominant, fitter population that could precipitate future outbreaks [16, 22]. In Europe, phylogeographic reconstruction using more than 1,000 ORF5 sequences demonstrated that live pig trade volume is the single most significant predictor of viral migration between countries, far outweighing geographic distance or pig density, a finding that has direct implications for targeted movement restrictions and compartmentalization strategies [59].

The Chinese Epidemiological Crucible

China represents the epicenter of PRRSV genetic diversity and evolution, a consequence of the world's largest swine population (~450 million head), high farm density, widespread use of multiple MLV strains, and intense viral circulation [1, 9, 19]. Currently, four major PRRSV-2 lineages co-circulate in Chinese swine herds: Lineage 8 (CH-1a-like and HP-PRRSV), Lineage 1 (NADC30-like and NADC34-like), Lineage 3 (QYYZ-like), and Lineage 5 (BJ-4-like), with Lineage 1 variants progressively displacing the historically dominant HP-PRRSV strains [1, 9, 19, 35]. The emergence of highly pathogenic PRRSV (HP-PRRSV) in 2006, characterized by a discontinuous 30-amino-acid deletion in nsp2 and associated with mortality rates exceeding 20% in growing pigs, marked a watershed moment in PRRSV evolution [6, 19, 30]. However, by the mid-2010s, HP-PRRSV began to wane in prevalence, gradually replaced by NADC30-like strains (introduced from the US via imported breeding pigs) that exhibit lower baseline virulence but a far greater propensity for recombination with endemic Chinese strains, generating chimeric viruses with unpredictable pathogenic potential [8, 10, 35, 36]. The NADC34-like lineage (sublineage 1.5), first detected in northeastern China in 2017 and sharing a characteristic 100-amino-acid deletion in nsp2 with the US IA/2014/NADC34 strain, has rapidly expanded its geographic footprint, and phylogenetic analyses suggest it is undergoing population expansion and may become the next dominant lineage in China [8, 25, 65]. Crucially, PRRSV-1 in China, long considered a sporadic and low-pathogenicity curiosity, has now diversified into at least seven independent subgroups, with the BJEU06-1-like subgroup becoming dominant and exhibiting enhanced pathogenicity characterized by high fever, weight loss, and moderate lung consolidation in experimental infections [7, 13, 58]. A 2022 isolate from an adult slaughter pig (SD1291) revealed a novel 4-aa deletion in nsp2 and a 5-aa deletion in the GP3/GP4 overlap region, demonstrating ongoing adaptive evolution in this previously overlooked species [13, 58].

Recombinogenesis as a Dominant Evolutionary Force

Recombination in PRRSV is not an occasional aberration but a persistent, high-frequency driver of genetic innovation that fundamentally shapes the epidemiological landscape. Multiple independent studies have demonstrated that inter-lineage recombination is detectable in a substantial proportion of field strains, with recombination breakpoints concentrated in specific genomic regions including the nsp2 hypervariable region, nsp9 (RNA-dependent RNA polymerase), and the structural protein region spanning ORF2 to ORF4 [16, 19, 21, 36]. The nonstructural protein 9 region has been identified as a prominent inter-lineage recombination hotspot in both Chinese and US strains, an observation of profound functional significance given nsp9's essential role in viral RNA replication and its interaction with host proteins such as ZAP [16, 38, 48]. The major recombination pattern in Chinese PRRSV-2 shifted dramatically between 2013 and 2018: during 1991-2013, the predominant backbone was Lineage 8 (HP-PRRSV), but by 2014-2018, the backbone had switched to Lineage 1 (NADC30-like), reflecting the emergence of new parental strains available for recombination [16]. This evolutionary flexibility has produced a series of notable multi-lineage recombinants with enhanced pathogenicity. The SCcd2020 strain, isolated in Sichuan province, represents a complex recombinant of NADC30-like, NADC34-like, and JXA1-like (Lineage 8) parents, causing 60% mortality in challenged piglets with severe hemorrhagic pneumonia [8]. Similarly, the SD17-38 strain emerged from recombination among three distinct lineages (NADC30, BJ-4, and TJ), inducing 40% mortality and harboring a unique serine/asparagine deletion and asparagine insertion in GP5 that was stably maintained through serial passage, suggesting positive selection for this novel antigenic configuration [36]. The TJnh2021 strain, another inter-lineage recombinant between NADC34-like (Lineage 1.5) and QYYZ-like (Lineage 3), caused 40% mortality in nursery piglets, exhibiting higher pathogenicity than previously reported Lineage 1.5 strains alone [11].

Recombination Involving Modified Live Vaccines

Perhaps the most concerning aspect of PRRSV recombinogenesis is the documented involvement of MLV strains as recombination partners with field viruses, a phenomenon that undermines vaccination strategies and can generate virulent progeny from attenuated parents. Reverse genetics studies have confirmed the theoretical feasibility of such events, and field surveillance has validated their occurrence [17, 21]. In Denmark, a recombination between two PRRSV-1 vaccine strains (Amervac and 96V198) produced a highly transmissible virus that caused severe clinical outbreaks in over 38 herds, despite the vaccine parents being attenuated, and spread over a distance of at least 5.8 km, implicating aerosol transmission [24]. In Iowa, USA, the field isolate IA70388-R was demonstrated by full-genome sequencing to be a natural recombinant between the Fostera PRRSV vaccine and a circulating field strain (IA76950-WT), recovered from pigs with interstitial pneumonia [26]. In China, the DJY-19 strain originated from recombination among NADC30, TJ (vaccine-derived), and JXA1-R (vaccine-derived) strains, directly demonstrating that multiple MLV applications within a region create a genetic melting pot from which novel recombinants can emerge [64]. Experimental work with chimeric viruses has shown that swapping the nsp2 region from HP-PRRSV into an NADC30-like backbone confers enhanced virulence properties including prolonged high fever and increased proinflammatory cytokine production, indicating that recombination can transfer virulence determinants between lineages [6]. Management practices, including the simultaneous use of multiple MLV strains, high pig density, and continuous swine movement, are theoretically predicted to exacerbate recombination rates by increasing the probability of co-infection of individual macrophages with genetically distinct viruses [21, 60].

Nsp2: The Hypervariable Hub of Genetic Diversity

The replicase nonstructural protein 2 (nsp2) coding region exhibits extraordinary genetic plasticity, characterized by a spectrum of insertions, deletions (indels), and substitutions that serve as a molecular fingerprint for lineage classification and a potential determinant of virulence [6, 9, 16]. A systematic analysis of 355 PRRSV-2 genomes from China and the US between 2014-2018 categorized nsp2 indel patterns into 25 distinct types, providing a novel classification framework that complements traditional ORF5-based phylogenetics [16]. The HP-PRRSV lineage is defined by a characteristic 30-aa discontinuous deletion (at positions 481 and 533-558 relative to VR-2332), which historically was considered a virulence marker, although subsequent studies have demonstrated that this deletion alone is insufficient to confer the HP-PRRSV phenotype [6, 9, 19]. NADC30-like strains harbor a larger, 131-aa deletion in nsp2 compared to the VR-2332 reference, while NADC34-like strains possess a 100-aa deletion, and these distinctive patterns facilitate rapid molecular identification [8, 25, 35]. Intriguingly, nsp2 variations are not merely epidemiological markers but have functional consequences: chimeric virus experiments swapping nsp2 between HP-PRRSV and NADC30-like backbones demonstrated that HP-PRRSV nsp2 is a critical regulator of virulence and persistence, modulating host immune responses including TLR4, IL-1β, and MPO expression in secondary lymphoid tissues [6]. This variation in immunomodulatory capacity may explain the evolutionary displacement of HP-PRRSV by NADC30-like strains, as the latter's less proinflammatory nsp2 could facilitate prolonged viral persistence and transmission [6, 19]. In PRRSV-1, the BJEU06-1-like subgroup that is becoming dominant in China is characterized by a 5-aa discontinuous deletion pattern (4+1) at positions 357-360 and 411 of nsp2, a pattern that emerged relatively recently and may be associated with enhanced fitness in the Chinese swine population [7, 13].

Within-Herd and Regional Transmission Dynamics

The transmission of PRRSV within and between farms is governed by a complex interplay of farm type, production flow, pig movement networks, and environmental factors, all of which contribute to the spatial and temporal heterogeneity of genetic diversity. Stochastic epidemiological modeling calibrated on weekly outbreak data from US production systems revealed that transmission routes differ sharply by farm type: for sow farms, 59% of infections were attributable to local (distance-dependent) spread, 36% to animal movements, and 5% to re-infection from within-herd persistence; in contrast, nursery farms experienced 80% of infections from animal movements, reflecting the downstream flow of infected pigs from sow herds [29]. A network autocorrelation study using 1,761 ORF5 sequences linked to 494 farms demonstrated that both primary and secondary (indirect) contacts with an infected farm increased the likelihood of PRRSV introduction, with a 23% increased risk from secondary contacts, a novel finding that highlights the importance of supply chain connectivity [60]. Geographic risk factors include pig density (500-1000 pigs/km²), proximity to major roads (0.5-0.7 km), and elevation below 41 meters, while dense vegetation and higher elevation serve as barriers to local dissemination [62]. Notably, the use of MLV or field virus inoculation on sow farms one year prior reduced the risk of L1A occurrence in downstream nurseries by 36%, suggesting that interventions at the breeding herd level propagate benefits through the production pyramid [60]. Aerosol transmission, while challenging to quantify definitively, has been implicated in farm-to-farm spread over distances up to several kilometers under favorable meteorological conditions, with evidence from both experimental studies and outbreak investigations, such as the Danish vaccine-recombinant outbreak where the index case was 5.8 km from the suspected source [24, 66].

Global Genetic Diversity and Emerging Threats

The PRRSV pandemic is characterized by a relentless emergence of novel variants, each with unique genetic configurations and pathogenic properties, necessitating continuous global surveillance and molecular characterization. In the United States, the RFLP 1-4-4 Lineage 1C variant that emerged in Iowa in 2020 was associated with 17.15% nursery mortality, prompting industry-wide alarm and highlighting the capacity of Lineage 1 to generate highly virulent sublineages even within a well-characterized genetic background [23]. In Peru, ORF5 sequencing of PRRSV strains from 14 farms revealed that 75% belonged to the RFLP 1-7-4 type, genetically clustered with the US 2013-2014 emergent strains, confirming the international spread of this virulent clade and the importance of import screening [63]. In China, the ZDXYL-China-2018-1 strain, an ORF5 RFLP 1-7-4-like virus from northern China, showed moderate pathogenicity with persistent fever and interstitial pneumonia, and genetic analysis placed it in the same lineage as US ISU10 and NADC34 strains, indicating that the 1-7-4 pandemic has become truly global [50, 65]. A metagenomic survey of adult slaughter pigs in China identified a PRRSV-1 strain (SD1291) with enhanced in vitro replication kinetics compared to earlier PRRSV-1 isolates, and the virus could only be isolated in primary alveolar macrophages (PAMs), not in Marc-145 cells, underscoring the cellular tropism differences that complicate diagnosis and vaccine matching [58]. The continuous importation of breeding pigs from North America and Europe serves as a recurring source of novel genetic material into Chinese swine populations, with four independent introduction events of PRRSV-1 documented through phylogenetic analysis of 88 complete genomes spanning 1991-2018 [13, 35]. As the Food and Agriculture Organization (FAO) has emphasized, the globalized nature of swine genetics trade means that no region is insulated from the emergence of new PRRSV variants, and coordinated international surveillance networks are essential for early detection and response [16, 59].

Evolutionary Dynamics and Recombination in PRRSV

Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) represents one of the most genetically complex and rapidly evolving pathogens affecting global swine production. The virus, a member of the family Arteriviridae within the order Nidovirales, possesses a single-stranded positive-sense RNA genome of approximately 15 kilobases. Since its emergence in the late 1980s in the United States and Europe, PRRSV has demonstrated a remarkable capacity for genetic diversification, driven by two primary mechanisms: the high error rate of its RNA-dependent RNA polymerase (RdRp) and homologous recombination [4, 17, 21]. This genetic plasticity has profound implications for viral fitness, immune evasion, vaccine efficacy, and disease control. Understanding the evolutionary dynamics and recombination patterns of PRRSV is therefore not merely an academic exercise but a critical component of contemporary swine health management. The virus is recognized by the World Organisation for Animal Health (WOAH) as a pathogen of significant economic consequence, costing the US swine industry an estimated $664 million annually, a figure that has increased from $560 million in 2005, reflecting the ongoing challenge of managing its genetic diversity [32].

The Molecular Basis of Genetic Diversity: Mutation and Quasispecies Evolution

The primary engine of PRRSV evolution is its error-prone replication machinery. The nonstructural protein 9 (nsp9), which harbors the RdRp activity, lacks a proofreading function, leading to an estimated mutation rate of approximately 10⁻² to 10⁻³ substitutions per nucleotide per year [15, 21]. This rate is among the highest observed for RNA viruses and results in the establishment of a dynamic quasispecies swarm, a population of closely related but genetically distinct viral variants coexisting within a single host. The N protein, encoded by ORF7, while relatively conserved, still accumulates mutations that influence diagnostic detection and immune recognition [3]. The GP5 protein, encoded by ORF5, is a major target for neutralizing antibodies and exhibits considerable hypervariability, particularly in its ectodomain. This region contains a conserved epitope flanked by N-glycosylation sites that can mask antibody recognition or mutate to escape neutralization, a classic example of antigenic drift [5, 44]. The open reading frame 5 (ORF5) gene is therefore the most common target for phylogenetic classification, with over 4,000 sequences analyzed in the US between 2009 and 2017 alone to track the temporal dynamics of co-circulating lineages [22].

The quasispecies nature of PRRSV infection is a critical concept for understanding its pathogenesis and persistence. The existence of a diverse mutant spectrum allows the virus to rapidly adapt to selective pressures, such as host immune responses, antiviral drugs, or cell culture adaptation. For instance, the emergence of highly pathogenic PRRSV (HP-PRRSV) in China, characterized by a discontinuous 30-amino-acid deletion in the nsp2 region, likely arose from the selection of a pre-existing variant within the quasispecies of a less virulent ancestor [1, 9, 19]. This evolutionary trajectory is not random; it is shaped by the interplay of mutation, selection, and genetic drift. The replicase protein nsp2 is a prominent hotspot for genetic variation, including deletions and insertions, which directly modulate viral virulence and persistence. Interlineage chimeric studies have demonstrated that swapping the nsp2 region from an HP-PRRSV strain into a low-virulence NADC30-like backbone conferred enhanced pathogenicity, including prolonged high fever and proinflammatory cytokine induction [6]. This work definitively established nsp2 as a key virulence regulator, highlighting how variation in this region can alter host-pathogen interactions at a fundamental level.

Recombination: A Major Driver of Large-Scale Genomic Change

While point mutations provide incremental change, homologous recombination facilitates the exchange of large genomic segments between distinct PRRSV strains, enabling sudden and dramatic shifts in viral phenotype. Recombination is a frequent and increasingly recognized event in PRRSV evolution, occurring when two different viral genomes coinfect the same host cell and the viral replication machinery switches templates during RNA synthesis [19, 21]. The frequency of these events is alarmingly high; genomic analyses reveal a high frequency of interlineage recombination hot spots, particularly in nonstructural protein 9 (nsp9) and the structural protein regions GP2 to GP3 [16]. Intralineage recombination hot spots are more scattered across the genome, but the overall trend is clear: recombination is a dominant force shaping the contemporary PRRSV landscape.

The molecular mechanism of recombination in PRRSV is primarily "copy-choice" recombination. During minus-strand RNA synthesis, the RdRp may dissociate from the original template and re-associate with a different template, incorporating genetic information from both viruses into the nascent genome. The replicase proteins nsp9 and nsp10, along with transmembrane nsps like nsp2, nsp3, and nsp5, form a complex interaction network that governs the replication and transcription complex (RTC) [38]. The efficiency of template switching is likely influenced by the structural compatibility of the co-infecting genomes and the presence of specific RNA sequences that promote pausing or dissociation of the polymerase. The consequences of recombination can be profound, leading to the emergence of novel chimeric viruses with altered pathogenicity, cell tropism, and antigenicity [8, 11, 36].

Global Recombination Patterns and the Emergence of Novel Strains

The geographic landscape of PRRSV recombination is dynamic, with different regions exhibiting unique patterns based on their circulating strain diversity. In China, the co-circulation of multiple lineages (Lineage 1 [NADC30-like], Lineage 3 [QYYZ-like], Lineage 5 [BJ-4-like], and Lineage 8 [HP-PRRSV-like]) has created a fertile environment for complex inter-lineage recombination events [1, 9, 19]. One of the most significant examples is the emergence of NADC30-like strains. Originally introduced from the United States around 2013, these strains have since undergone extensive recombination with Chinese domestic HP-PRRSV strains (e.g., JXA1-like, TJ-like) and occasionally with PRRSV-1 strains, giving rise to a plethora of novel variants [10, 35, 64]. A study from 2017 identified a novel highly pathogenic recombinant (SD17-38) derived from three distinct lineages (NADC30, BJ-4, and TJ), which caused 40% mortality in piglets and contained a unique deletion and insertion in the GP5 protein, never before described in the literature [36].

The emergence of NADC34-like PRRSV-2 in China further exemplifies the role of recombination in establishing new endemic strains. These viruses, first detected in northeastern China in 2017, share a 100-amino-acid deletion in nsp2 with the US IA/2014/NADC34 strain. Recombination analysis revealed that five out of eight complete genome sequences of these viruses were derived from recombination between IA/2014/NADC34 and either ISU30 (a lineage 1 strain) or NADC30 [25]. More recently, a novel highly pathogenic recombinant (SCcd2020) was identified that combined elements from NADC30-like, NADC34-like, and JXA1-like strains, representing the first description of HP-PRRSV involvement in an NADC34-like recombination event. This particular recombinant caused 60% mortality in challenged piglets, underscoring the potential for recombination to dramatically escalate virulence [8]. Similarly, the TJnh2021 strain represented a recombination between NADC34-like (lineage 1.5) and QYYZ-like (lineage 3) viruses, resulting in a 40% mortality rate [11]. These events are not isolated; they are part of a pervasive trend where recombinant strains are becoming the dominant circulating viruses in China, with the major recombination pattern shifting from an L8 backbone to an L1 (NADC30-like) backbone between 2014 and 2018 [16, 19].

The Role of Modified Live Vaccines in Shaping Evolutionary Dynamics

The widespread use of modified live virus (MLV) vaccines has introduced another layer of complexity into PRRSV evolution. While MLVs are effective at reducing clinical disease and virus shedding against homologous challenge, they are "leaky" vaccines that do not provide sterilizing immunity. Critically, MLVs can replicate in vaccinated pigs, shed into the environment, and potentially revert to virulence or recombine with circulating field strains [17, 41]. This has been documented in multiple field cases. In Denmark, a recombination between two PRRSV-1 MLV strains (Amervac and 96V198) resulted in a highly transmissible virus that caused severe outbreaks in previously negative herds, despite the parental strains being attenuated [24]. In the United States, a natural recombinant (IA70388-R) was isolated from pigs in Iowa and was demonstrated to be a hybrid of the Fostera PRRSV MLV and a wild-type field strain (IA76950-WT) [26]. These findings demonstrate that MLV strains are not inert; they actively participate in the viral gene pool.

Vaccine-derived strains can also act as major parents in recombination events, providing the replicase and transcription complex that drives replication. The introduction of MLVs into a population already harboring a diverse quasispecies can accelerate the emergence of novel variants through both selection and recombination. For instance, in China, the widespread use of the Inglevac PRRS MLV (derived from a lineage 5 strain) and the JXA1-R vaccine (derived from an HP-PRRSV strain) has been implicated in the creation of complex recombinants that are not only more pathogenic but also better adapted to evade vaccine-induced immunity [17, 64]. Management practices that exacerbate or mitigate recombination include immunization strategies, swine movements, and regional swine density, all of which influence the likelihood of co-infection and the mixing of different viral genomes [21]. The theoretical risk of MLV-induced recombination is now an empirically validated reality, raising significant concerns about the long-term sustainability of current vaccination strategies.

Evolutionary Drivers: Immune Selection and Strain Turnover

The immune system of the host exerts a powerful selective pressure on PRRSV evolution. The rapid emergence and sequential turnover of dominant lineages in the field is consistent with a model of immune-mediated selection. As a host population builds immunity through natural infection or vaccination against the most common variant, a niche is created for a newly emerging variant that is antigenically distinct and can escape the pre-existing immunity [22]. This phenomenon has been observed in the US, where lineage 9 was the most prevalent from 2009 to 2010, but its occurrence dropped to 0.5% after 2014, coinciding with the emergence of lineage 1 as the dominant lineage. Analysis of patterns of non-synonymous and synonymous mutations in ORF5 has revealed evidence of positive selection acting on immunologically important regions, particularly the GP5 ectodomain. The virus's ability to modulate both innate and adaptive immunity is central to this process. PRRSV employs a multi-pronged strategy to evade host defenses, including antagonizing type I interferon (IFN) production through nsp1, nsp2, nsp4, and nsp11, degrading antiviral proteins like DDX10 via selective autophagy, and interfering with the JAK-STAT signaling pathway [45-47, 49]. This robust immune evasion not only facilitates persistent infection but also allows for a longer period of viral replication and diversification, increasing the probability of generating escape mutants.

The evolutionary dynamics of PRRSV are also influenced by host factors. For example, young pigs are more susceptible to PRRSV infection than adults, a phenomenon linked not to differences in CD163 receptor expression but to age-related differences in the intrinsic innate immune response of macrophages [42]. This suggests that the intracellular environment of the host cell, including the baseline expression of interferon-stimulated genes (ISGs), can shape which viral variants are most successful. Furthermore, the abundance of the CD163 receptor on porcine alveolar macrophages acts as a pivotal switch for infection; cells with low CD163 abundance are resistant, while those with high abundance support efficient replication [39]. This cellular heterogeneity within the host provides another layer of selection, potentially favoring viral variants that can enter cells with lower receptor density or that can upregulate CD163 expression.

Conclusion and Path Forward

The evolutionary dynamics and recombination of PRRSV present a formidable and continuously evolving challenge to the global swine industry. The virus's high mutation rate, combined with frequent homologous recombination, generates a remarkable degree of genetic and antigenic diversity. This diversity, in turn, fuels the emergence of new strains with altered virulence, transmissibility, and antigenicity, often rendering existing vaccines ineffective. The active participation of MLV strains in this evolutionary process further complicates control efforts, turning a tool of prevention into a potential source of new pathogenic variants. Moving forward, a comprehensive strategy is required. This must include enhanced genomic surveillance using whole-genome sequencing to rapidly identify emerging recombinants [16, 21], the development of next-generation vaccines that target more conserved epitopes and provide broader cross-protection [41, 44], and potentially the implementation of gene-edited pigs resistant to infection [2, 27, 31]. Understanding the complex interaction network of nonstructural proteins [38] and the host factors that restrict viral replication [48] offers promising targets for novel antiviral drugs and host-directed therapies. Only through a deep and integrated understanding of PRRSV evolution can we hope to develop rational, sustainable strategies for its prevention and control.

Diagnostic Approaches for PRRSV Detection and Surveillance

The accurate and timely detection of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) is the cornerstone of effective disease management, control, and eradication programs. The extraordinary genetic and antigenic diversity of PRRSV, driven by its error-prone RNA-dependent RNA polymerase (RdRp) and frequent recombination events, presents a formidable challenge to diagnostic accuracy and surveillance efficacy [1, 4, 21]. As the virus continues to evolve, with the emergence of novel recombinant strains such as NADC30-like, NADC34-like, and complex inter-lineage chimeras, diagnostic methodologies must be continuously refined to maintain sensitivity, specificity, and the capacity to differentiate circulating field strains from vaccine-derived viruses [8, 10, 11, 64]. The diagnostic landscape for PRRSV encompasses a tiered approach, ranging from traditional virus isolation and serological assays to advanced molecular techniques and high-throughput sequencing platforms, each with distinct applications, advantages, and limitations within the context of herd-level surveillance and individual animal diagnosis [67].

Classical and Serological Diagnostic Methods

Virus Isolation (VI) remains the definitive gold standard for PRRSV detection, providing a viable isolate for further characterization, antigenic analysis, and vaccine matching. The primary cell substrates for VI are primary porcine alveolar macrophages (PAMs) and the African green monkey kidney cell line Marc-145, although some field strains, particularly certain PRRSV-1 isolates, exhibit a strict tropism for PAMs and fail to replicate in continuous cell lines [42, 58]. The susceptibility of PAMs is intrinsically linked to the surface expression level of the CD163 scavenger receptor, which acts as a pivotal switch for viral uncoating and genome release; cells with low CD163 abundance are refractory to infection, while high expression permits efficient viral replication [39, 55]. Despite its utility, VI is labor-intensive, time-consuming (often requiring 3-7 days), and suffers from relatively low sensitivity compared to nucleic acid amplification tests, particularly when samples are degraded or contain low viral loads [67]. Furthermore, the genetic variability of PRRSV can lead to isolation failure if the chosen cell line lacks the appropriate receptor conformation for a given variant [58].

Serological assays are indispensable for monitoring herd exposure, evaluating vaccine take, and classifying herd status according to established systems [68]. The most widely employed serological tool is the enzyme-linked immunosorbent assay (ELISA) , which detects antibodies against the viral nucleocapsid (N) protein. The N protein is highly immunogenic and abundantly expressed during infection, making it an ideal target for serodiagnosis [3]. Commercial ELISAs are rapid, cost-effective, and amenable to high-throughput screening, allowing veterinarians to assess seroprevalence within a population. However, a critical limitation is that N-protein-based ELISAs cannot differentiate between antibodies induced by natural infection and those elicited by modified-live virus (MLV) vaccines, as all current MLVs express the N protein [17, 41]. This inability to distinguish infected from vaccinated animals (DIVA) complicates surveillance in vaccinated herds. Alternative serological methods, such as the immunoperoxidase monolayer assay (IPMA) and indirect immunofluorescence assay (IFA) , offer higher specificity and can be used to confirm ELISA results or detect antibodies against specific viral proteins, but they are more labor-intensive and subjective in interpretation [67]. The detection of neutralizing antibodies, primarily directed against glycoprotein 5 (GP5) and the GP2/GP3/GP4 complex, provides insight into protective immunity, but these assays are complex, require live virus, and are not routinely used for surveillance [5, 37].

Molecular Detection: The Cornerstone of Modern Diagnostics

Reverse transcription polymerase chain reaction (RT-PCR) , particularly in its real-time quantitative format (RT-qPCR), has become the diagnostic method of choice for acute PRRSV detection due to its exceptional sensitivity, specificity, and rapid turnaround time [67]. RT-qPCR assays typically target conserved regions of the viral genome, such as ORF7 (encoding the N protein) or ORF1b (encoding the RdRp), to ensure broad reactivity across diverse PRRSV-1 and PRRSV-2 lineages [15, 21]. The high sensitivity of RT-qPCR allows for the detection of viral RNA in serum, oral fluids, lung tissue, and semen, often before the onset of clinical signs or seroconversion. This capability is critical for early outbreak detection and for monitoring the effectiveness of elimination protocols [68]. The development of SYBR Green I-based duplex real-time PCR assays has enabled the simultaneous detection of PRRSV and other common swine pathogens, such as porcine circovirus 3 (PCV-3), facilitating the diagnosis of complex coinfections that are increasingly recognized in the field [14, 72].

Conventional RT-PCR followed by Sanger sequencing of the ORF5 gene remains the standard for molecular epidemiology and phylogenetic characterization. ORF5 sequencing provides a cost-effective means to genotype circulating strains, identify restriction fragment length polymorphism (RFLP) patterns, and track the introduction and spread of specific lineages, such as the virulent RFLP 1-7-4 lineage 1C variant that emerged in the United States and subsequently spread to South America and Asia [23, 50, 63]. However, reliance on ORF5 alone can be misleading, as recombination events frequently occur elsewhere in the genome, particularly within nsp2, nsp9, and the GP2-GP3 region [16, 21]. A virus may possess an ORF5 sequence characteristic of one lineage while harboring a replicase complex from a completely different parental strain, as demonstrated by the NADC34-like recombinant SCcd2020, which clusters with NADC34-like strains by ORF5 but with NADC30-like viruses by whole-genome analysis [8, 11]. Therefore, whole-genome sequencing (WGS) is increasingly advocated to fully resolve the genetic identity of novel or unusual PRRSV isolates and to accurately identify recombination breakpoints [21, 64].

Digital PCR (dPCR) represents a next-generation advancement in nucleic acid quantification, offering absolute quantification of target molecules without the need for standard curves. This technology provides higher precision and sensitivity than RT-qPCR, particularly at low viral loads, and is more tolerant of PCR inhibitors often present in clinical samples [67]. dPCR is emerging as a valuable tool for quantifying viral reservoirs in persistently infected animals and for validating the endpoint of elimination protocols, where residual low-level viremia must be detected with certainty.

Isothermal and Point-of-Care Technologies

The need for rapid, field-deployable diagnostics has driven the development of isothermal amplification methods that circumvent the requirement for thermal cyclers. Loop-mediated isothermal amplification (LAMP) and recombinase polymerase amplification (RPA) can amplify PRRSV nucleic acid at a constant temperature (typically 37-65°C) within 30 minutes, providing a potential solution for on-farm testing [67]. The integration of RPA with CRISPR-Cas systems has further enhanced the sensitivity and specificity of isothermal detection. The CRISPR-Cas12a and CRISPR-Cas13a systems leverage the collateral cleavage activity of these nucleases: upon target recognition by a guide RNA, the Cas enzyme non-specifically cleaves a fluorescent reporter molecule, generating a detectable signal [69, 70]. The RT-RPA-Cas12a assay developed by Liu et al. achieved single-copy sensitivity for PRRSV detection in a single-tube, isothermal reaction completed in 25 minutes, with no cross-reactivity to other porcine viruses [69]. Similarly, the Cas13a-based method demonstrated a detection limit of 172 copies/μL and enabled visual readout, making it suitable for resource-limited settings [70]. These CRISPR-based platforms hold immense promise for real-time surveillance at the point of production, but their widespread adoption requires validation against large panels of genetically diverse field strains and integration into robust, user-friendly devices.

Advanced Genomic Surveillance and Metagenomics

The escalating genetic complexity of PRRSV, characterized by frequent recombination between vaccine and field strains [24, 26] and the emergence of multi-lineage chimeras [36, 64], necessitates a paradigm shift from targeted sequencing to unbiased, high-resolution genomic surveillance. Metagenomic next-generation sequencing (mNGS) offers a powerful, hypothesis-free approach to pathogen detection, capable of identifying PRRSV alongside coinfecting agents such as Streptococcus suis, Salmonella Choleraesuis, and porcine circoviruses without a priori knowledge of the pathogen [14, 20, 71]. Li et al. successfully employed mNGS to characterize a novel PRRSV-1 strain (SD1291) from an adult slaughter pig, revealing unique deletions in nsp2 and the GP3-GP4 overlap region that were not detectable by conventional ORF5 typing [58]. WGS data provides the resolution necessary to map recombination breakpoints with nucleotide precision, identify signatures of positive selection in immunologically important regions (e.g., GP5 ectodomain), and track the phylodynamic and phylogeographic spread of viral lineages across production systems and geographic regions [16, 22, 59].

Phylodynamic analyses, integrating genomic data with epidemiological metadata, have demonstrated that live pig trade is the major determinant of PRRSV migration between countries in Europe, far outweighing factors such as pig density or vaccination status [59]. In the United States, network autocorrelation modeling has revealed that both primary and secondary contacts within animal movement networks significantly increase the risk of a farm acquiring a specific PRRSV sub-lineage, such as L1A (RFLP 1-7-4) [60]. These insights underscore the critical importance of genomic surveillance in informing risk-based biosecurity interventions. However, the implementation of WGS and mNGS in routine veterinary diagnostics is constrained by cost, bioinformatics expertise, and the need for standardized interpretation pipelines [21]. The World Organisation for Animal Health (WOAH) recognizes the value of such advanced molecular tools but emphasizes the need for validation against reference standards to ensure data comparability across laboratories.

Surveillance Strategies and Herd Classification

Effective PRRSV surveillance extends beyond individual animal diagnosis to encompass systematic, population-based monitoring. The Holtkamp classification system, revised in 2021, provides a standardized framework for categorizing breeding herd PRRSV status based on diagnostic testing protocols [68]. Herds are classified as Positive Unstable (active viral circulation with clinical signs), Positive Stable (virus present but no evidence of active transmission in breeding animals), Provisional Negative, or Negative. The recommended diagnostic cadence for promotion to a higher status involves repeated RT-qPCR testing of processing fluids, oral fluids, and serum, combined with serological profiling to confirm the absence of recent infection [68]. For growing pigs, classification focuses on the presence or absence of viremia and the timing of infection relative to placement.

The choice of diagnostic specimen is critical for surveillance sensitivity. Oral fluids, collected by allowing pigs to chew on cotton ropes, offer a cost-effective, population-level sample that can detect PRRSV RNA days before individual serum samples become positive. Processing fluids (tissues and blood collected during castration and tail docking) provide a valuable sample for monitoring sow herd stability. Air filtration and aerosol sampling have been explored for environmental surveillance, given evidence of airborne PRRSV transmission over short distances, but the sensitivity of these methods remains variable and highly dependent on environmental conditions [29, 66]. The integration of machine learning algorithms with biosecurity audit data and diagnostic results is an emerging frontier, enabling the identification of specific management practices (e.g., trailer sharing, employee turnover, farm density) that most strongly predict PRRSV outbreak risk [28]. Such interpretable models can guide targeted interventions to reduce the force of infection at the farm and regional level.

In conclusion, the diagnostic armamentarium for PRRSV has expanded dramatically, from classical VI and serology to sophisticated molecular, isothermal, and genomic platforms. The optimal diagnostic strategy is not a one-size-fits-all approach but must be tailored to the specific objective, whether it be acute outbreak confirmation, herd classification, vaccine efficacy monitoring, or molecular epidemiological surveillance. The relentless evolution of PRRSV, particularly through recombination, demands that diagnostic targets be continuously re-evaluated and that WGS become a more routine component of surveillance programs to capture the true genetic landscape of this economically devastating pathogen.

Immune Responses and Immunopathology of PRRSV Infection

The interplay between porcine reproductive and respiratory syndrome virus (PRRSV) and the host immune system is a masterclass in viral immunopathogenesis, characterized by a profound and multifaceted dysregulation of both innate and adaptive immunity. PRRSV has evolved a sophisticated arsenal of strategies to subvert, delay, and manipulate host defenses, leading to a state of immune dysregulation that facilitates persistent infection, enhances susceptibility to secondary pathogens, and drives the severe immunopathology observed in clinical disease. This section provides an exhaustive analysis of the molecular and cellular mechanisms governing the immune response to PRRSV and the subsequent pathological consequences, drawing upon the latest research to delineate the complex host-pathogen interface.

Subversion of Innate Immunity: The Frontline of Defense is Breached

The innate immune system constitutes the first line of defense against viral invasion, with the induction of type I interferons (IFN-α/β) representing a critical antiviral response. PRRSV, however, is a master antagonist of this pathway, employing a multi-pronged attack to ensure its replication and survival. The virus’s nonstructural proteins (nsps) are the primary weapons in this arsenal. Specifically, nsp1α, nsp1β, nsp2, nsp4, and nsp11 have all been implicated in the suppression of IFN induction [46, 47]. Nsp1, for instance, has been shown to inhibit the activation of interferon regulatory factor 3 (IRF3) and nuclear factor kappa B (NF-κB), key transcription factors for IFN-β expression, while also interfering with the JAK-STAT signaling pathway downstream of the IFN receptor [47, 57]. Transcriptome analysis of macrophages expressing PRRSV nsp1 reveals a broad suppression of genes involved in early inflammatory responses, including those within the IL-17, chemokine, and TNF-α signaling pathways, effectively blinding the host’s initial immune surveillance [57].

A particularly potent mechanism of innate immune evasion involves the viral nsp11, which encodes a nidovirus-specific endoribonuclease (NendoU). Beyond its role in viral RNA processing, nsp11 acts as a potent IFN antagonist by directly targeting IRF9, a crucial component of the ISGF3 transcription factor complex that drives the expression of interferon-stimulated genes (ISGs) [49]. By binding to IRF9, nsp11 prevents the formation and nuclear translocation of ISGF3, thereby crippling the cell’s ability to establish an antiviral state even in the presence of IFN [49]. This NendoU activity-independent mechanism reveals a sophisticated strategy to block the amplification of the antiviral response. Furthermore, PRRSV actively degrades host antiviral proteins. The envelope (E) protein, for example, targets the antiviral enzyme cholesterol 25-hydroxylase (CH25H) for degradation via the ubiquitin-proteasome pathway, thereby neutralizing its broad antiviral activity and its ability to inhibit viral replication [53]. Similarly, the E protein orchestrates the degradation of the DEAD-box helicase DDX10, a positive regulator of type I IFN production, through SQSTM1/p62-dependent selective autophagy [45]. This dual strategy of suppressing IFN production and signaling, coupled with the targeted degradation of antiviral effectors, ensures that the innate immune response is severely blunted from the earliest stages of infection.

The Role of Autophagy and Cellular Stress in Viral Replication and Pathogenesis

PRRSV’s manipulation extends beyond classical immune signaling to encompass fundamental cellular homeostatic processes, most notably autophagy. While autophagy can serve as an antiviral defense mechanism, PRRSV has hijacked this pathway to its advantage. The virus activates autophagy to facilitate its replication, a process that is intricately linked to lipid metabolism. PRRSV infection downregulates N-Myc downstream-regulated gene 1 (NDRG1), which in turn activates lipophagy, the autophagic degradation of lipid droplets [52]. This process liberates free fatty acids, which are then utilized to fuel viral replication and progeny virus assembly [52]. This represents a novel mechanism where the virus co-opts a host catabolic process to secure the metabolic resources necessary for its propagation.

The unfolded protein response (UPR), a cellular stress response triggered by the accumulation of misfolded proteins in the endoplasmic reticulum (ER), is another pathway exploited by PRRSV. The virus actively reprograms the UPR for its own benefit. PRRSV degrades the UPR central regulator GRP78 while activating both the IRE1-XBP1s and PERK-eIF2α-ATF4 signaling branches [34]. Critically, the activated transcription factor ATF4 is diverted from its normal nuclear function to the viral replication complexes, where it promotes viral RNA synthesis [34]. This subversion of a stress response pathway into a pro-viral mechanism highlights the extraordinary adaptability of PRRSV. Furthermore, the virus manipulates the autophagic machinery to degrade antiviral proteins. As mentioned, the E protein uses selective autophagy to degrade DDX10, but this is just one example. The intricate balance between the host’s attempt to use autophagy for pathogen clearance and the virus’s exploitation of the same pathway for replication and immune evasion is a central theme in PRRSV pathogenesis [45, 73].

Immunopathology: The Cytokine Storm and Endothelial Barrier Dysfunction

The failure of the innate immune system to control PRRSV does not result in immunological silence; rather, it leads to a dysregulated and damaging inflammatory response. This is particularly evident in infections with highly pathogenic PRRSV (HP-PRRSV) strains, which induce a fulminant “cytokine storm” characterized by excessive production of pro-inflammatory cytokines such as IL-1β, TNF-α, and IL-6 [6, 51]. This hypercytokinemia is a primary driver of the severe clinical signs, including high fever, anorexia, and acute respiratory distress. The nonstructural protein nsp2 has been identified as a critical virulence factor that modulates this inflammatory response. Chimeric virus studies have shown that swapping the nsp2 from an HP-PRRSV strain into a low-virulence backbone confers the ability to induce prolonged high fever and a significant increase in pro-inflammatory cytokines, highlighting nsp2’s role as a master regulator of immune activation and virulence [6].

The consequences of this cytokine storm are devastating, particularly within the lung. The pulmonary microvascular endothelial barrier, which is essential for maintaining fluid homeostasis and preventing edema, is a key target of PRRSV-induced immunopathology. Pro-inflammatory cytokines IL-1β and TNF-α, secreted by infected alveolar macrophages, act synergistically to disrupt this barrier [43]. These cytokines dysregulate the expression of tight junction proteins, specifically by downregulating claudin-8 and upregulating claudin-4 in pulmonary microvascular endothelial cells (PMVECs) [43]. This disruption is mediated by a complex signaling cascade involving the nuclear accumulation of transcription factors like ILF2, GTF3C2, and THRAP3, as well as the post-transcriptional suppression of claudin-8 by ssc-miR-185 [43]. The resulting increase in vascular permeability leads to protein-rich fluid leakage into the alveolar space, causing pulmonary edema and contributing directly to the acute lung injury and acute respiratory distress syndrome (ARDS) that are hallmarks of severe PRRS [43]. The Notch signaling pathway also contributes to this inflammatory cascade, as its activation in infected macrophages is required for the full expression of TNF-α and IL-1β [51].

Adaptive Immunity: A Delayed and Dysfunctional Response

The adaptive immune response to PRRSV is characteristically slow and weak, a direct consequence of the virus’s successful subversion of the innate system. The humoral response is particularly problematic. While a rapid, non-neutralizing antibody response develops against the nucleocapsid (N) protein, neutralizing antibodies (nAbs) appear late, often not until 3-4 weeks post-infection, and are directed primarily against the major envelope glycoprotein GP5 [5, 40]. The induction of nAbs is further hampered by the presence of a “decoy” epitope and extensive N-linked glycosylation on GP5, which shields critical neutralizing epitopes from immune recognition [5, 37]. This phenomenon, known as “glycan shielding,” is a major obstacle to vaccine development, as it allows the virus to persist and replicate in the face of an ongoing antibody response. The N protein itself, while highly immunogenic, is not a target for neutralization and may even contribute to immune dysregulation [3].

The cellular immune response, while more critical for viral clearance, is also impaired. PRRSV-specific T-cell responses, particularly IFN-γ-secreting cells, are delayed and of low magnitude [40, 74]. The T-helper (CD4+) cell response peaks around the time of viremia resolution, suggesting a role in controlling infection, while cytotoxic T lymphocytes (CTLs) are more prominent in the lungs [74]. However, the virus actively suppresses T-cell function. The γδ T-cell population, which acts as a bridge between innate and adaptive immunity, is also modulated, with PRRSV inducing their expression of the lymph node homing receptor CCR7, potentially altering their trafficking and function [74]. Furthermore, PRRSV infection can lead to an increase in regulatory T cells (Tregs) and the immunosuppressive cytokine IL-10, which further dampens the antiviral T-cell response and contributes to a state of immune exhaustion [46, 54]. This profound suppression of adaptive immunity explains why the virus can establish persistent infections and why current modified-live virus (MLV) vaccines, which themselves can cause immunosuppression, provide only partial and inconsistent protection, especially against heterologous strains [17, 41].

Enhanced Susceptibility to Secondary Infections: The Gateway for Co-infections

The immunomodulatory effects of PRRSV have a devastating practical consequence: a dramatically increased susceptibility to secondary bacterial and viral infections. This is a hallmark of PRRSV pathogenesis and a major contributor to the economic losses associated with the disease [14, 18]. The virus’s ability to disable alveolar macrophage function, the very cells responsible for clearing bacterial pathogens from the lung, creates a permissive environment for opportunistic invaders. PRRSV co-infection with Streptococcus suis serotype 2 (SS2) is a classic example, where the virus enhances the invasion and proliferation of the bacteria in the blood and tissues, leading to more severe pneumonia, myocarditis, and higher mortality [56]. Similarly, PRRSV infection predisposes pigs to severe disease from Salmonella Choleraesuis, creating a pathogenic synergy that results in more extensive lung pathology and higher rates of bacterial colonization [20]. The virus also frequently co-circulates with porcine circovirus type 2 (PCV2), and co-infection is associated with the development of porcine circovirus-associated disease (PCVAD) [14, 71]. This immunosuppressive state is so profound that it can even be partially counteracted by direct-fed microbials (DFMs) that stimulate innate immunity, suggesting that the PRRSV-induced immune paralysis is a key therapeutic target [20]. The ability of PRRSV to act as a gateway for a wide range of other pathogens underscores its role as a primary driver of the porcine respiratory disease complex (PRDC) and a major challenge to swine health management [14, 37].

Novel Control Strategies: Gene Editing and Modified Live Vaccines

The intractable nature of porcine reproductive and respiratory syndrome virus (PRRSV), characterized by its extraordinary genetic plasticity, propensity for recombination, and sophisticated immune evasion strategies, has rendered conventional control measures, including biosecurity, management practices, and existing vaccines, insufficient for eradication or even reliable long-term suppression. The persistent economic burden, estimated at approximately $664 million annually in the United States alone [32] and with individual farrow-to-finish operations facing losses exceeding €650,000 per year under severe endemic scenarios [18], has galvanized research into fundamentally different paradigms of intervention. Among the most promising and provocative frontiers are two distinct yet complementary approaches: (1) the generation of genetically edited pigs bearing targeted modifications to the host-encoded viral receptor CD163, conferring heritable resistance to infection, and (2) the rational redesign of modified live virus (MLV) vaccines using reverse genetics to enhance safety, stability, and cross-protective breadth while minimizing the risks of reversion to virulence and recombination with field strains. These strategies represent a departure from traditional immunological approaches, instead leveraging precision molecular biology to disrupt the virus-host axis at its most fundamental levels.

Genetic Disruption of the CD163–PRRSV Axis: From Proof-of-Concept to Commercial-Scale Production

The identification of CD163, a scavenger receptor cysteine-rich (SRCR) domain-containing protein expressed on the surface of porcine alveolar macrophages (PAMs) and other monocyte-lineage cells, as the indispensable entry mediator for both PRRSV-1 and PRRSV-2, provided a rational molecular target for genetic intervention. Landmark studies demonstrated that deletion of exon 7, which encodes SRCR domain 5 (SRCR5), using CRISPR/Cas9 editing in porcine zygotes produced pigs that were completely resistant to infection with a highly virulent PRRSV-1 subtype 2 strain [31]. These ΔSRCR5 CD163 pigs exhibited no viremia, no seroconversion, and no histopathological evidence of viral replication in lung or lymphoid tissues following challenge, in stark contrast to wild-type controls that developed fulminant disease. Crucially, the edited protein retained expression on the macrophage surface and preserved its biological function in hemoglobin-haptoglobin complex clearance, thus avoiding the potential adverse effects associated with a complete CD163 knockout [31]. Subsequent investigations extended these findings to PRRSV-2, demonstrating that a short region of the SRCR5 domain, including the ligand-binding pocket, could be deleted in Liang Guang Small Spotted and Large White pigs via CRISPR/Cas9, rendering them fully resistant to infection with highly pathogenic JXA1 and MY strains [27]. In these studies, edited pigs showed no clinical signs, no pathological lung abnormalities, no detectable viremia, and no anti-PRRSV antibody response, while PAMs isolated from the edited animals similarly resisted infection in vitro [27].

A particularly elegant refinement involved substituting porcine CD163 exon 7 with the corresponding exon from human CD163-like 1 (hCD163L1), generating a chimeric receptor that retained endocytic functionality but abrogated PRRSV entry at the post-binding step, specifically inhibiting virus uncoating and genome release [30]. When challenged with highly pathogenic PRRSV, CD163Mut/Mut pigs displayed dramatically reduced viral loads, alleviated fever, and, in a stark demonstration of the survival benefit, three of four edited pigs survived to the termination of the experiment, whereas all wild-type controls succumbed to infection [30]. These results collectively established that precision editing of a single host locus could confer complete or near-complete resistance across diverse PRRSV genotypes, a feat unattainable by any vaccine platform.

The translation of this technology from academic proof-of-concept to commercially viable application represents a watershed moment. In a first-of-its-kind scaled gene editing program, Burger et al. [2] utilized CRISPR-Cas to introduce a single modified CD163 allele into four genetically diverse, elite porcine lines, producing a founder population of healthy pigs that were subsequently confirmed resistant to PRRSV infection by both macrophage and animal challenges. This achievement addresses the critical bottleneck of genetic diversity: for widespread commercial adoption, the resistance trait must be introgressed into the diverse breeding stock that underpins global pork production without compromising other economically valuable traits such as growth rate, feed efficiency, or meat quality. The establishment of this founder population paves the way for multiplication, distribution, and, pending regulatory approval, commercial deployment [2]. The World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) have recognized the potential of gene-edited livestock for improving animal health and welfare, though regulatory frameworks vary considerably across jurisdictions, and public acceptance remains an evolving variable.

The Modified Live Vaccine Conundrum: Attenuation, Instability, and the Recombination Crisis

For over three decades, MLVs have been the cornerstone of PRRSV control worldwide, and their development and application provide essential context for understanding the rationale behind next-generation vaccine design. The first commercially available MLV, RespPRRS/Repro (Ingelvac PRRS MLV), derived from the VR-2332 strain by serial passage in cell culture, demonstrated efficacy against homologous challenge but quickly revealed its limitations in the face of the virus's staggering diversity. While MLVs can reduce clinical signs and viral shedding against homologous strains, they consistently fail to confer sterilizing immunity against heterologous field isolates, a shortfall that has been extensively documented [4, 17]. This "leakiness" is not merely an inconvenience; it is a fundamental driver of the virus's evolution and persistence in endemic populations. Because MLV-vaccinated pigs can still become infected with and transmit field viruses, the vaccine contributes to an epidemiological milieu in which multiple viral lineages co-circulate, creating conditions permissive for recombination [17, 21].

The most disturbing consequence of MLV use is the documented role of vaccine strains as progenitors of novel, often virulent, recombinant viruses. A seminal event occurred in Denmark in 2019, where a severe outbreak involving a boar station and 38 downstream herds was traced to a recombinant virus derived from two different PRRSV-1 MLV strains: the Amervac strain (Unistrain PRRS, Hipra) and the 96V198 strain (Suvaxyn PRRS, Zoetis AH) [24]. The major parent (96V198) contributed the 5' portion of the genome spanning ORFs 1–2 and part of ORF3, while the minor parent (Amervac) contributed the remainder; this chimeric virus proved highly transmissible and caused severe clinical disease despite its vaccine origin [24]. Similarly, in the United States, a natural recombinant between the Fostera PRRSV vaccine strain and a field strain (IA76950-WT) was isolated from pigs with interstitial pneumonia in Iowa, confirming that MLV-field recombination is not a rare event but an ongoing biosafety concern [26]. In China, where multiple MLV strains (including JXA1-R, TJ-F, and HuN4-F112) have been widely deployed, the genomic landscape has become a patchwork of vaccine-derived sequences. The DJY-19 strain, isolated from a Sichuan farm, was shown to have a chimeric genome with breakpoints separating regions highly similar to the TJ strain, the JXA1-R vaccine strain, and the NADC30 field strain [64]. Even more alarming, the SD17-38 isolate represented a three-lineage recombinant involving NADC30 (lineage 1), BJ-4 (lineage 5, which is itself nearly identical to the RespPRRS MLV [9]), and TJ (lineage 8), causing 40% mortality in challenged piglets [36]. These findings are not anomalous; systematic analyses have revealed that the major recombination pattern for Chinese PRRSVs during 2014–2018 shifted from a lineage 8 backbone to a lineage 1 backbone, with NADC30-like strains proving particularly recombination-prone [16]. The NSP2 region, in particular, has been identified as a hotspot for both inter- and intra-lineage recombination, and its hypervariability directly modulates viral virulence and persistence [6, 16].

Reverse Genetics and Rational Vaccine Design: Engineering Stability and Efficacy

In response to the inherent instability and recombination liability of traditionally attenuated MLVs, reverse genetics systems have emerged as a powerful platform for designing vaccines with defined attenuating mutations that are genetically stable, incapable of reverting to virulence, and less prone to recombination. Infectious cDNA clones for PRRSV, first reported in 1998, allow for precise manipulation of the viral genome, including site-directed mutagenesis, targeted gene deletions, gene swaps between strains, and the insertion of foreign immunogens [33]. This toolkit has been deployed to address the specific deficits of PRRSV MLVs.

One rational approach targets the viral immune evasion machinery. PRRSV encodes multiple nonstructural proteins (nsps) that antagonize the host type I interferon (IFN) response, including nsp1α and nsp1β (which suppress IFN induction via multiple mechanisms) and nsp11, which inhibits IFN signaling by targeting IRF9 and impairing ISGF3 complex formation [49]. By engineering deletions or point mutations in these IFN-antagonist domains, it is possible to create viruses that trigger a more robust innate immune response, leading to enhanced adaptive immunity and, potentially, broader cross-protection. Similarly, mutations in nsp2, which has been identified as a critical regulator of virulence and persistence through its modulation of proinflammatory cytokine responses (e.g., TLR4, IL-1β, MPO), can be introduced to fine-tune the balance between attenuation and immunogenicity [6].

Another promising avenue involves codon deoptimization, a strategy that was not explicitly discussed in the provided sources but is conceptually analogous to the broader application of reverse genetics for stability. By systematically replacing synonymous codons in essential viral genes with rarely used codons, viral protein expression can be reduced without altering the amino acid sequence, resulting in an attenuated phenotype that is genetically locked and cannot revert to virulence through single nucleotide changes. The NSP9 protein, encoding the RNA-dependent RNA polymerase (RdRp), is an ideal target for this approach due to its essential role in replication and its relatively high sequence conservation; importantly, NSP9 also contains T cell epitopes that are beneficial for vaccine-induced cellular immunity [15]. Furthermore, the N protein, which plays critical roles in viral replication, virulence modulation, and host immune evasion, represents an additional target for rational attenuation strategies [3].

Finally, the epitope atlas approach, leveraging structural biology and machine learning, offers a path toward immunogen design that could circumvent the traditional live-vaccine paradigm entirely. By identifying 75 epitope locations on PRRSV proteins crucial for infection and computationally designing 56 stable immunogen peptides with optimized flanking sequences and linkers, it is now possible to engineer multi-valent antigens that target conserved, functionally constrained epitopes, reducing the likelihood of immune escape [44]. While such subunit or virus-like particle vaccines are not technically MLVs, their design is directly informed by reverse genetics and structural virology, and they could be delivered via replication-competent viral vectors (e.g., adenovirus, alphavirus replicons) to achieve robust T-cell and B-cell responses without the risks associated with PRRSV MLV replication and recombination [41].

The path forward for novel control strategies demands an integrated approach. Gene editing offers the prospect of herd-level resistance, but its impact on the evolutionary dynamics of PRRSV, specifically, whether it will drive selection for CD163-independent entry pathways, requires long-term surveillance. The rational redesign of MLVs through reverse genetics addresses the critical safety and efficacy gaps of current vaccines, but regulatory hurdles and the challenge of achieving broad cross-protection against a rapidly diversifying pathogen remain substantial. Together, however, these strategies represent a decisive break from the cycle of incomplete immunity and viral evolution that has characterized the PRRSV control effort for the past three decades.

References

[1] Zhou L, Han J, Yang H. The evolution and diversity of porcine reproductive and respiratory syndrome virus in China.. Veterinary Microbiology. 2024. DOI: https://doi.org/10.1016/j.vetmic.2024.110252

[2] Burger BT, Beaton B, Campbell MA, Brett B, Rohrer MS, Plummer S, et al.. Generation of a Commercial-Scale Founder Population of Porcine Reproductive and Respiratory Syndrome Virus Resistant Pigs Using CRISPR-Cas. The CRISPR Journal. 2024. DOI: https://doi.org/10.1089/crispr.2023.0061

[3] Zheng Y, Li G, Luo Q, Sha H, Zhang H, Wang R, et al.. Research progress on the N protein of porcine reproductive and respiratory syndrome virus. Frontiers in Microbiology. 2024. DOI: https://doi.org/10.3389/fmicb.2024.1391697

[4] Fiers J, Cay A, Maes D, Tignon M. A Comprehensive Review on Porcine Reproductive and Respiratory Syndrome Virus with Emphasis on Immunity. Vaccines. 2024. DOI: https://doi.org/10.3390/vaccines12080942

[5] Luo Q, Zheng Y, Zhang H, Yang Z, Sha H, Kong W, et al.. Research Progress on Glycoprotein 5 of Porcine Reproductive and Respiratory Syndrome Virus. Animals. 2023. DOI: https://doi.org/10.3390/ani13050813

[6] Kong C, Li D, Hu Y, Gao P, Zhang Y, Zhou L, et al.. The Genetic Variation of Porcine Reproductive and Respiratory Syndrome Virus Replicase Protein nsp2 Modulates Viral Virulence and Persistence. Journal of Virology. 2023. DOI: https://doi.org/10.1128/jvi.01689-22

[7] Sun Q, Xu H, An T, Cai X, Tian Z, Zhang H. Recent Progress in Studies of Porcine Reproductive and Respiratory Syndrome Virus 1 in China. Viruses. 2023. DOI: https://doi.org/10.3390/v15071528

[8] Zhou L, Yu J, Zhou J, Long Y, Xiao L, Fan Y, et al.. A novel NADC34-like porcine reproductive and respiratory syndrome virus 2 with complex genome recombination is highly pathogenic to piglets.. Infection, Genetics and Evolution. 2023. DOI: https://doi.org/10.1016/j.meegid.2023.105436

[9] Guo Z, Chen X, Li R, Qiao S, Zhang G. The prevalent status and genetic diversity of porcine reproductive and respiratory syndrome virus in China: a molecular epidemiological perspective. Virology Journal. 2018. DOI: https://doi.org/10.1186/s12985-017-0910-6

[10] Yu Y, Zhang Q, Cao Z, Tang Y, Xia D, Wang G, et al.. Recent Advances in Porcine Reproductive and Respiratory Syndrome Virus NADC30-Like Research in China: Molecular Characterization, Pathogenicity, and Control. Frontiers in Microbiology. 2022. DOI: https://doi.org/10.3389/fmicb.2021.791313

[11] Sun Y, Liu Y, Yang J, Li W, Yu X, Wang S, et al.. Recombination between NADC34-like and QYYZ-like strain of Porcine Reproductive and Respiratory Syndrome virus with high pathogenicity for piglets in China.. Transboundary and Emerging Diseases. 2022. DOI: https://doi.org/10.1111/tbed.14471

[12] Zhang H, Sha H, Qin L, Wang N, Kong W, Huang L, et al.. Research Progress in Porcine Reproductive and Respiratory Syndrome Virus–Host Protein Interactions. Animals. 2022. DOI: https://doi.org/10.3390/ani12111381

[13] Yu F, Liu L, Tian X, Chen L, Huang X, Sun Y, et al.. Genomic Analysis of Porcine Reproductive and Respiratory Syndrome Virus 1 Revealed Extensive Recombination and Potential Introduction Events in China. Veterinary Sciences. 2022. DOI: https://doi.org/10.3390/vetsci9090450

[14] Zhao D, Yang B, Yuan X, Shen C, Zhang D, Shi X, et al.. Advanced Research in Porcine Reproductive and Respiratory Syndrome Virus Co-infection With Other Pathogens in Swine. Frontiers in Veterinary Science. 2021. DOI: https://doi.org/10.3389/fvets.2021.699561

[15] Sha H, Zhang H, Chen Y, Huang L, Zhao M, Wang N. Research Progress on the NSP9 Protein of Porcine Reproductive and Respiratory Syndrome Virus. Frontiers in Veterinary Science. 2022. DOI: https://doi.org/10.3389/fvets.2022.872205

[16] Yu F, Yan Y, Shi M, Liu H, Zhang H, Yang Y, et al.. Phylogenetics, Genomic Recombination, and NSP2 Polymorphic Patterns of Porcine Reproductive and Respiratory Syndrome Virus in China and the United States in 2014–2018. Journal of Virology. 2020. DOI: https://doi.org/10.1128/JVI.01813-19

[17] Zhou L, Ge X, Yang H. Porcine Reproductive and Respiratory Syndrome Modified Live Virus Vaccine: A “Leaky” Vaccine with Debatable Efficacy and Safety. Vaccines. 2021. DOI: https://doi.org/10.3390/vaccines9040362

[18] Nathues H, Alarcón P, Rushton J, Jolie R, Fiebig K, Jiménez M, et al.. Cost of porcine reproductive and respiratory syndrome virus at individual farm level - An economic disease model.. Preventive Veterinary Medicine. 2017. DOI: https://doi.org/10.1016/j.prevetmed.2017.04.006

[19] Jiang Y, Li G, Yu L, Li L, Zhang Y, Zhou Y, et al.. Genetic Diversity of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) From 1996 to 2017 in China. Frontiers in Microbiology. 2020. DOI: https://doi.org/10.3389/fmicb.2020.00618

[20] Zuckermann F, Husmann RJ, Chen W, Roady P, Pfeiff J, Leistikow KR, et al.. Bacillus-Based Direct-Fed Microbial Reduces the Pathogenic Synergy of a Coinfection with Salmonella enterica Serovar Choleraesuis and Porcine Reproductive and Respiratory Syndrome Virus. Infection and Immunity. 2022. DOI: https://doi.org/10.1128/iai.00574-21

[21] Risser J, Ackerman MS, Evelsizer R, Wu S, Kwon B, Hammer J. Porcine reproductive and respiratory syndrome virus genetic variability a management and diagnostic dilemma. Virology Journal. 2021. DOI: https://doi.org/10.1186/s12985-021-01675-0

[22] Paploski I, Corzo C, Rovira A, Murtaugh M, Sanhueza J, Vilalta C, et al.. Temporal Dynamics of Co-circulating Lineages of Porcine Reproductive and Respiratory Syndrome Virus. Frontiers in Microbiology. 2019. DOI: https://doi.org/10.3389/fmicb.2019.02486

[23] Trevisan G, Li G, Moura C, Coleman K, Thomas P, Zhang J, et al.. Complete Coding Genome Sequence of a Novel Porcine Reproductive and Respiratory Syndrome Virus 2 Restriction Fragment Length Polymorphism 1-4-4 Lineage 1C Variant Identified in Iowa, USA. Microbiology Resource Announcements. 2021. DOI: https://doi.org/10.1128/MRA.00448-21

[24] Kvisgaard LK, Kristensen CS, Ryt-Hansen P, Pedersen K, Stadejek T, Trebbien R, et al.. A recombination between two Type 1 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV‐1) vaccine strains has caused severe outbreaks in Danish pigs. Transboundary and Emerging Diseases. 2020. DOI: https://doi.org/10.1111/tbed.13555

[25] Xu H, Song S, Zhao J, Leng C, Fu J, Li C, et al.. A potential endemic strain in China: NADC34-like porcine reproductive and respiratory syndrome virus.. Transboundary and Emerging Diseases. 2020. DOI: https://doi.org/10.1111/tbed.13508

[26] Wang A, Chen Q, Wang L, Madson D, Harmon K, Gauger P, et al.. Recombination between Vaccine and Field Strains of Porcine Reproductive and Respiratory Syndrome Virus. Emerging Infectious Diseases. 2019. DOI: https://doi.org/10.3201/eid2512.191111

[27] Guo C, Wang M, Zhu Z, He S, Liu H, Liu X, et al.. Highly Efficient Generation of Pigs Harboring a Partial Deletion of the CD163 SRCR5 Domain, Which Are Fully Resistant to Porcine Reproductive and Respiratory Syndrome Virus 2 Infection. Frontiers in Immunology. 2019. DOI: https://doi.org/10.3389/fimmu.2019.01846

[28] Sykes AL, Silva GS, Holtkamp D, Mauch BW, Osemeke O, Linhares DCL, et al.. Interpretable machine learning applied to on-farm biosecurity and porcine reproductive and respiratory syndrome virus.. Transboundary and Emerging Diseases. 2021. DOI: https://doi.org/10.1111/tbed.14369

[29] Galvis J, Prada J, Corzo C, Machado G. Modeling the transmission and vaccination strategy for porcine reproductive and respiratory syndrome virus.. Transboundary and Emerging Diseases. 2021. DOI: https://doi.org/10.1111/tbed.14007

[30] Chen J, Wang H, Bai J, Liu W, Liu X, Yu D, et al.. Generation of Pigs Resistant to Highly Pathogenic-Porcine Reproductive and Respiratory Syndrome Virus through Gene Editing of CD163. International Journal on Biological Sciences. 2019. DOI: https://doi.org/10.7150/ijbs.25862

[31] Burkard C, Opriessnig T, Mileham A, Stadejek T, Ait-Ali T, Lillico S, et al.. Pigs Lacking the Scavenger Receptor Cysteine-Rich Domain 5 of CD163 Are Resistant to Porcine Reproductive and Respiratory Syndrome Virus 1 Infection. Journal of Virology. 2018. DOI: https://doi.org/10.1128/JVI.00415-18

[32] Holtkamp D, Kliebenstein J, Neumann E, Zimmerman J, Rotto H, Yoder TK, et al.. Assessment of the economic impact of porcine reproductive and respiratory syndrome virus on United States pork producers. Journal of swine health and production. 2013. DOI: https://doi.org/10.54846/jshap/754

[33] Chaudhari J, Vu H. Porcine Reproductive and Respiratory Syndrome Virus Reverse Genetics and the Major Applications. Viruses. 2020. DOI: https://doi.org/10.3390/v12111245

[34] Gao P, Chai Y, Song J, Liu T, Chen P, Zhou L, et al.. Reprogramming the unfolded protein response for replication by porcine reproductive and respiratory syndrome virus. PLoS Pathogens. 2019. DOI: https://doi.org/10.1371/journal.ppat.1008169

[35] Zhou L, Wang Z, Ding Y, Ge X, Guo X, Yang H. NADC30-like Strain of Porcine Reproductive and Respiratory Syndrome Virus, China. Emerging Infectious Diseases. 2015. DOI: https://doi.org/10.3201/eid2112.150360

[36] Chen N, Ye M, Li S, Huang Y, Zhou R, Yu X, et al.. Emergence of a novel highly pathogenic recombinant virus from three lineages of porcine reproductive and respiratory syndrome virus 2 in China 2017. Transboundary and Emerging Diseases. 2018. DOI: https://doi.org/10.1111/tbed.12952

[37] Stoian A, Rowland R. Challenges for Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Design: Reviewing Virus Glycoprotein Interactions with CD163 and Targets of Virus Neutralization. Veterinary Sciences. 2019. DOI: https://doi.org/10.3390/vetsci6010009

[38] Song J, Liu Y, Gao P, Hu Y, Chai Y, Zhou S, et al.. Mapping the Nonstructural Protein Interaction Network of Porcine Reproductive and Respiratory Syndrome Virus. Journal of Virology. 2018. DOI: https://doi.org/10.1128/JVI.01112-18

[39] Wang T, Liu Y, Li L, Wang G, Wang H, Zhang H, et al.. Porcine alveolar macrophage CD163 abundance is a pivotal switch for porcine reproductive and respiratory syndrome virus infection. OncoTarget. 2018. DOI: https://doi.org/10.18632/oncotarget.24040

[40] Rahe MC, Murtaugh M. Mechanisms of Adaptive Immunity to Porcine Reproductive and Respiratory Syndrome Virus. Viruses. 2017. DOI: https://doi.org/10.3390/v9060148

[41] Li J, Miller LC, Sang Y. Current Status of Vaccines for Porcine Reproductive and Respiratory Syndrome: Interferon Response, Immunological Overview, and Future Prospects. Vaccines. 2024. DOI: https://doi.org/10.3390/vaccines12060606

[42] Gray DK, Dvorak C, Robinson SR, Murtaugh M. Characterization of age-related susceptibility of macrophages to porcine reproductive and respiratory syndrome virus.. Virus Research. 2019. DOI: https://doi.org/10.1016/j.virusres.2019.01.015

[43] Sun W, Wu W, Fang X, Ge X, Zhang Y, Han J, et al.. Disruption of pulmonary microvascular endothelial barrier by dysregulated claudin-8 and claudin-4: uncovered mechanisms in porcine reproductive and respiratory syndrome virus infection. Cellular and Molecular Life Sciences. 2024. DOI: https://doi.org/10.1007/s00018-024-05282-4

[44] Dey S, Bruner J, Brown MH, Roof M, Chowdhury R. Identification and biophysical characterization of epitope atlas of Porcine Reproductive and Respiratory Syndrome Virus. Computational and Structural Biotechnology Journal. 2024. DOI: https://doi.org/10.1016/j.csbj.2024.08.029

[45] Li J, Zhou Y, Zhao W, Liu J, Ullah R, Fang P, et al.. Porcine reproductive and respiratory syndrome virus degrades DDX10 via SQSTM1/p62-dependent selective autophagy to antagonize its antiviral activity. Autophagy. 2023. DOI: https://doi.org/10.1080/15548627.2023.2179844

[46] Chen X, Qiao S, Li R, Wang J, Li X, Zhang G. Evasion strategies of porcine reproductive and respiratory syndrome virus. Frontiers in Microbiology. 2023. DOI: https://doi.org/10.3389/fmicb.2023.1140449

[47] Wang T, Sun M, Zhang H, Wang G, Zhan G, Tian Z, et al.. Evasion of Antiviral Innate Immunity by Porcine Reproductive and Respiratory Syndrome Virus. Frontiers in Microbiology. 2021. DOI: https://doi.org/10.3389/fmicb.2021.693799

[48] Zhao Y, Song Z, Bai J, Liu X, Nauwynck H, Jiang P. ZAP, a CCCH-Type Zinc Finger Protein, Inhibits Porcine Reproductive and Respiratory Syndrome Virus Replication and Interacts with Viral Nsp9. Journal of Virology. 2019. DOI: https://doi.org/10.1128/JVI.00001-19

[49] Wang D, Chen J, Yu C, Zhu X, Xu S, Fang L, et al.. Porcine Reproductive and Respiratory Syndrome Virus nsp11 Antagonizes Type I Interferon Signaling by Targeting IRF9. Journal of Virology. 2019. DOI: https://doi.org/10.1128/JVI.00623-19

[50] Xie C, Ha Z, Zhang H, Zhang Y, Xie Y, Zhang H, et al.. Pathogenicity of porcine reproductive and respiratory syndrome virus (ORF5 RFLP 1-7-4 viruses) in China.. Transboundary and Emerging Diseases. 2020. DOI: https://doi.org/10.1111/tbed.13549

[51] Lu Y, Zhang Y, Xiang X, Sharma M, Liu K, Wei J, et al.. Notch signaling contributes to the expression of inflammatory cytokines induced by highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) infection in porcine alveolar macrophages. Developmental and Comparative Immunology. 2020. DOI: https://doi.org/10.1016/j.dci.2020.103690

[52] Wang J, Liu J, Shao K, Han Y, Li G, Ming S, et al.. Porcine Reproductive and Respiratory Syndrome Virus Activates Lipophagy To Facilitate Viral Replication through Downregulation of NDRG1 Expression. Journal of Virology. 2019. DOI: https://doi.org/10.1128/JVI.00526-19

[53] Ke W, Fang L, Tao R, Li Y, Jing H, Wang D, et al.. Porcine Reproductive and Respiratory Syndrome Virus E Protein Degrades Porcine Cholesterol 25-Hydroxylase via the Ubiquitin-Proteasome Pathway. Journal of Virology. 2019. DOI: https://doi.org/10.1128/JVI.00767-19

[54] Lee J, Kim Y, Kim J, Cho C, Jeon J, Park J, et al.. Nasal delivery of chitosan/alginate nanoparticle encapsulated bee (Apis mellifera) venom promotes antibody production and viral clearance during porcine reproductive and respiratory syndrome virus infection by modulating T cell related responses.. Veterinary Immunology and Immunopathology. 2018. DOI: https://doi.org/10.1016/j.vetimm.2018.04.006

[55] Ge M, Xiao Y, Chen H, Luo F, Du G, Zeng F. Multiple antiviral approaches of (–)‐epigallocatechin‐3‐gallate (EGCG) against porcine reproductive and respiratory syndrome virus infection in vitro. Antiviral Research. 2018. DOI: https://doi.org/10.1016/j.antiviral.2018.07.012

[56] Li J, Wang J, Liu Y, Yang J, Guo L, Ren S, et al.. Porcine reproductive and respiratory syndrome virus NADC30‐like strain accelerates Streptococcus suis serotype 2 infection in vivo and in vitro. Transboundary and Emerging Diseases. 2019. DOI: https://doi.org/10.1111/tbed.13072

[57] Park I, Choi Y, Lee K, Chun T. Transcriptome analysis of pig macrophages expressing porcine reproductive and respiratory syndrome virus non-structural protein 1.. Veterinary Immunology and Immunopathology. 2020. DOI: https://doi.org/10.1016/j.vetimm.2020.110147

[58] Li C, Qiu M, Li S, Sun Z, Huang Z, Qi W, et al.. Metagenomic and Pathogenic Assessments Identify a Pathogenic Porcine Reproductive and Respiratory Syndrome Virus 1 with New Deletions from Adult Slaughter Pig in 2022. Transboundary and Emerging Diseases. 2023. DOI: https://doi.org/10.1155/2023/1975039

[59] Franzo G, Faustini G, Legnardi M, Cecchinato M, Drigo M, Tucciarone C. Phylodynamic and phylogeographic reconstruction of porcine reproductive and respiratory syndrome virus (PRRSV) in Europe: Patterns and determinants. Transboundary and Emerging Diseases. 2022. DOI: https://doi.org/10.1111/tbed.14556

[60] Makau D, Paploski I, Corzo C, VanderWaal K. Dynamic network connectivity influences the spread of a sub-lineage of porcine reproductive and respiratory syndrome virus.. Transboundary and Emerging Diseases. 2021. DOI: https://doi.org/10.1111/tbed.14016

[61] Lin W, Kaewprom K, Wang S, Lin C, Yang C, Chiou M, et al.. Outbreak of Porcine Reproductive and Respiratory Syndrome Virus 1 in Taiwan. Viruses. 2020. DOI: https://doi.org/10.3390/v12030316

[62] Jara M, Rasmussen DA, Corzo C, Machado G. Porcine reproductive and respiratory syndrome virus dissemination across pig production systems in the United States.. Transboundary and Emerging Diseases. 2020. DOI: https://doi.org/10.1111/tbed.13728

[63] Ramírez M, Bauermann FV, Navarro D, Rojas M, Manchego A, Nelson E, et al.. Detection of porcine reproductive and respiratory syndrome virus (PRRSV) 1-7-4-type strains in Peru.. Transboundary and Emerging Diseases. 2019. DOI: https://doi.org/10.1111/tbed.13134

[64] Zhao J, Zhu L, Huang J, Yang Z, Xu L, Gu S, et al.. Genetic characterization of a novel recombined porcine reproductive and respiratory syndrome virus 2 among Nadc30‐like, Jxa1‐like and TJ‐like strains. Veterinary Medicine and Science. 2020. DOI: https://doi.org/10.1002/vms3.402

[65] Xie C, Ha Z, Nan F, Zhang Y, Zhang H, Li J, et al.. Characterization of porcine reproductive and respiratory syndrome virus (ORF5 RFLP 1-7-4 viruses) in northern China.. Microbial Pathogenesis. 2019. DOI: https://doi.org/10.1016/j.micpath.2019.103941

[66] Arruda A, Tousignant S, Sanhueza J, Vilalta C, Poljak Z, Torremorell M, et al.. Aerosol Detection and Transmission of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV): What Is the Evidence, and What Are the Knowledge Gaps?. Viruses. 2019. DOI: https://doi.org/10.3390/v11080712

[67] Pan J, Zeng M, Zhao M, Huang L. Research Progress on the detection methods of porcine reproductive and respiratory syndrome virus. Frontiers in Microbiology. 2023. DOI: https://doi.org/10.3389/fmicb.2023.1097905

[68] Holtkamp D, Torremorell M, Corzo C, Linhares D, Almeida M, Yeske P, et al.. Proposed modifications to porcine reproductive and respiratory syndrome virus herd classification. Journal of swine health and production. 2021. DOI: https://doi.org/10.54846/jshap/1218

[69] Liu S, Tao D, Liao Y, Yang Y, Sun S, Zhao Y, et al.. Highly Sensitive CRISPR/Cas12a-Based Fluorescence Detection of Porcine Reproductive and Respiratory Syndrome Virus.. ACS Synthetic Biology. 2021. DOI: https://doi.org/10.1021/acssynbio.1c00103

[70] Chang Y, Deng Y, Li T, Wang J, Wang T, Tan F, et al.. Visual detection of porcine reproductive and respiratory syndrome virus using CRISPR-Cas13a.. Transboundary and Emerging Diseases. 2020. DOI: https://doi.org/10.1111/tbed.13368

[71] Chen N, Huang Y, Ye M, Li S, Xiao Y, Cui B, et al.. Co-infection status of classical swine fever virus (CSFV), porcine reproductive and respiratory syndrome virus (PRRSV) and porcine circoviruses (PCV2 and PCV3) in eight regions of China from 2016 to 2018.. Infection, Genetics and Evolution. 2019. DOI: https://doi.org/10.1016/j.meegid.2018.12.011

[72] Zheng L, Chai L, Tian R, Zhao Y, Chen H, Wang Z. Simultaneous detection of porcine reproductive and respiratory syndrome virus and porcine circovirus 3 by SYBR Green І-based duplex real-time PCR.. Molecular and Cellular Probes. 2020. DOI: https://doi.org/10.1016/j.mcp.2019.101474

[73] Chen X, Yu Z, Li W. Molecular mechanism of autophagy in porcine reproductive and respiratory syndrome virus infection. Frontiers in Cellular and Infection Microbiology. 2024. DOI: https://doi.org/10.3389/fcimb.2024.1434775

[74] Kick A, Amaral AF, Cortes L, Fogle J, Crisci E, Almond G, et al.. The T-Cell Response to Type 2 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV). Viruses. 2019. DOI: https://doi.org/10.3390/v11090796